Category: Healthcare Policy & IP

Presumed Consent in Pharmacy: When Pharmacists Can Substitute Without Asking

Learn how presumed consent laws allow pharmacists to substitute generic drugs without asking in 43 states. Discover exceptions for biosimilars and narrow therapeutic index drugs.

Read more

Predicting Generic Entry: How to Forecast Drug Patent Cliffs and Market Loss

Learn how to accurately forecast generic drug entry using patent data, FDA timelines, and competitive intelligence. Avoid costly prediction errors and prepare for patent cliffs.

Read more

Regulatory Exclusivity: How Non-Patent Protections Shape Drug Markets

Explore how regulatory exclusivity provides non-patent market protections for drugs. Learn about Hatch-Waxman, FDA rules, and the economic impact on pharmaceutical innovation.

Read more

Generic Drug Quality Standards: FDA Requirements and Testing Explained

Explore FDA requirements for generic drug quality, including bioequivalence testing, cGMP standards, and how generics compare to brand-name medications in safety and efficacy.

Read more

Complex Generic Drugs: Why FDA Approval Is Harder and Slower

Complex generic drugs face steep FDA approval hurdles due to intricate formulations and delivery devices. Learn why bioequivalence is harder to prove, costs are higher, and competition remains low.

Read more

ACA Plans and Generic Coverage: How Insurance Formularies Save You Money

Learn how ACA plans use insurance formularies to determine generic drug coverage costs. Discover how to navigate drug tiers, prior authorizations, and maximize your savings in 2026.

Read more

How to Verify Recall Notices and Affected Medication Lots: A Step-by-Step Guide

Learn how to verify recall notices and affected medication lots efficiently. This guide covers FDA classifications, 7-step verification protocols, manual vs. automated systems, and common pitfalls to ensure patient safety.

Read more

Medicare Part D Drug Coverage Explained for Patients (2026 Guide)

A clear guide to Medicare Part D drug coverage for 2026. Learn about the new $2,000+ out-of-pocket cap, how the three coverage phases work, and tips for choosing the right plan.

Read more

Authorized Generics: The Brand-Name Drug at a Generic Price

Discover how authorized generics offer the exact same formula as brand-name drugs at lower prices. Learn the differences from traditional generics, insurance coverage, and when to switch for better value.

Read more

Paragraph IV Patent Challenges: How Generic Makers Challenge Brands

Discover how generic drug manufacturers use Paragraph IV certifications to challenge brand-name patents under the Hatch-Waxman Act. Learn about the 180-day exclusivity, FDA approval timelines, and the economic impact on drug prices.

Read more

Hospital Formulary Economics: How Institutions Select Generics

Explore how hospitals balance cost, safety, and supply chain risks when selecting generic drugs. Learn about P&T committees, complex generics, and the economic pressures shaping modern formulary decisions.

Read more

How Insurers Choose Which Generics to Cover: The P&T Committee Process Explained

Discover how insurance formularies determine generic drug coverage. Learn about P&T committee decisions, formulary tiers, and how to handle exceptions when your medication isn't covered.

Read more